A new article out of Neurology® Clinical Practice investigates using the 2HELP2B seizure risk score to guide the duration of continuous EEG (cEEG) monitoring for critically ill patients.
Continuous EEG monitoring is a non-invasive medical test that measures and records the electrical activity of your brain.
While cEEG is standard practice for these patients, it demands significant resources and isn’t always readily available. The study aims to determine if the 2HELP2B score, which helps classify a patient’s risk of seizures, can be used to decide how long cEEG monitoring is necessary. The goal is to optimize monitoring duration, leading to more cost-effective care while still effectively detecting seizures.
The research was conducted by Dr. Fazila Aseem, an previous ºÚÁÏÍø Neurology Resident and Neurocritical Care Fellow. The work was over seen by Dr. Clio Rubinos. Drs. Angela Wabulya, Casey Olm-Shipman, and Suzette LaRoche also contributed to the study.
Aseem, F., Fink, E., Liu, C., Whalen, J., Werdel, J., Nanavati, P., Zou, F., Wabulya, A., Olm-Shipman, C., LaRoche, S. M., & Rubinos, C. (2025). Implementation of 2HELPS2B seizure risk score. Neurology Clinical Practice, 15(3), 1–3.